跳至主要内容
临床试验/JPRN-UMIN000038177
JPRN-UMIN000038177已完成未知

Efficacy and safety after switching from tenofovir disoproxil fumarate to tenofovir alafenamide containing antiretroviral therapy in virologically suppressed HIV-infected patients - Efficacy and safety after switching from tenofovir disoproxil fumarate to tenofovir alafenamide containing antiretroviral therapy in virologically suppressed HIV-infected patients

Kyushu University Hospital Department of General internal medicine0 个研究点目标入组 120 人开始时间: 2019年10月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients are inadequate to include in this study

研究者

发起方
Kyushu University Hospital Department of General internal medicine

相似试验

已完成
3 期
Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks: a prospective, open-label, randomized controlled trialTenofovir disoproxil fumarate (TDF)&#45induced nephrotoxicity in HIV infected patientsTDF induced nephrotoxicity&#44switching&#44virological response&#44abacavir&#44lopinavir/ritonavir
TCTR20190708002none84
招募中
不适用
Efficacy of entecavir-to-tenofovir switching treatment to attain a drug-free state in chronic hepatitis B: a randomized controlled trialchronic hepatitis B
JPRN-UMIN000021793Department of Hepatology, Osaka Metropolitan University90
进行中(未招募)
3 期
An Efficacy of Continuing Tenofovir Versus Switching Entecavir to Tenofovir in Treatment of Chronic Hepatitis B Patients : A Comparative StudyChronic hepatitis BTenofovirEntecavirSwitching
TCTR20160125002Chulabhorn Hospital300
招募中
不适用
Efficacy and safety of switching from entecavir to tenofovir for chronic hepatitis B patients with sustained viral supression: a randomized controlled trialchronic hepatitis B
JPRN-UMIN000018406Toranomon Hospital100
招募中
3 期
Outcome of early switching of Tenofovir Disoproxil Fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective studyTDF&#45induced proximal renal tubulopathyComplete recoveryHIV
TCTR20190307003/A64